Overview

Sulfamethoxazole Drug Interaction Study With MMX® Mesalazine/Mesalamine

Status:
Completed
Trial end date:
2011-12-20
Target enrollment:
Participant gender:
Summary
This is a drug interaction study evaluating the pharmacokinetic profiles of Sulfamethoxazole administered alone & in combination with Multi MatriX system (MMX®) formulation of mesalazine/mesalazine (Lialda®; Mesavancol®; Mezavant®) (MMX Mesalazine/mesalamine).
Phase:
Phase 1
Details
Lead Sponsor:
Shire
Treatments:
Mesalamine
Sulfamethoxazole